Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Infection in 2019 (COVID-19)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04880694
What this trial is testing

Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia

Who this might be right for
Severe COVID-19 Pneumonia
Grand Medical Pty Ltd. 25
Testing effectiveness (Phase 2)Study completedNCT04686773
What this trial is testing

Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention

Who this might be right for
COVID-19
R-Pharm 100
Post-approval studies (Phase 4)UnknownNCT05220280
What this trial is testing

SOLIDARITY Finland Plus Long-COVID

Who this might be right for
Covid19Coronavirus Disease 2019SARS-CoV-2 Acute Respiratory Disease
Clinical Urology and Epidemiology Working Group 400
Not applicableEnded earlyNCT05059080
What this trial is testing

A Six-Month Follow-Up Study of Participants With Coronavirus Disease 2019 (COVID-19) Previously Enrolled in a RO7496998 (AT-527) Study

Who this might be right for
COVID-19Long COVID
Hoffmann-La Roche 72
Large-scale testing (Phase 3)Looking for participantsNCT07743580
What this trial is testing

Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease

Who this might be right for
SARS-CoV-2
Shionogi 2,000
Not applicableStudy completedNCT04425213
What this trial is testing

Obesity and Mortality of Critically Ill Patients With COVID-19

Who this might be right for
COVIDSevere Acute Respiratory SyndromeObesity+1 more
Central Hospital, Nancy, France 250
Testing effectiveness (Phase 2)Study completedNCT04481685
What this trial is testing

A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
University of Kansas Medical Center 20
Early research (Phase 1)Study completedNCT04519437
What this trial is testing

Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19

Who this might be right for
HealthyChronic Stable Illness
Regeneron Pharmaceuticals 974
Testing effectiveness (Phase 2)Study completedNCT04380701
What this trial is testing

A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults

Who this might be right for
Infections, RespiratoryVirus DiseasesInfection Viral+3 more
BioNTech SE 512
Early research (Phase 1)Study completedNCT05505448
What this trial is testing

A Trial to Learn if a COVID-19 Therapeutic is Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants

Who this might be right for
Healthy
Regeneron Pharmaceuticals 48
Testing effectiveness (Phase 2)Ended earlyNCT04511650
What this trial is testing

Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019

Who this might be right for
COVID-19Acute Respiratory Distress Syndrome (ARDS)
EyePoint Pharmaceuticals, Inc. 31
Post-approval studies (Phase 4)Active Not RecruitingNCT07266558
What this trial is testing

Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 30,000
Testing effectiveness (Phase 2)Ended earlyNCT04342897
What this trial is testing

LY3127804 in Participants With COVID-19

Who this might be right for
COVID-19Pneumonia
Eli Lilly and Company 95
Not applicableStudy completedNCT04379310
What this trial is testing

Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019)

Who this might be right for
Covid-19
Istanbul Nisantasi University 54
Testing effectiveness (Phase 2)Study completedNCT04551898
What this trial is testing

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
BeiGene 181
Not applicableStudy completedNCT04430023
What this trial is testing

Epidemiological and Demographic Data From 150 Patients Diagnosed With Coronavirus Disease 2019 Pneumonia

Who this might be right for
Corona Virus InfectionPneumoniaAcute Respiratory Failure
Sisli Hamidiye Etfal Training and Research Hospital 150
Large-scale testing (Phase 3)Study completedNCT05449405
What this trial is testing

Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-I

Who this might be right for
COVID-19Symptoms and SignsCOVID-19 Pandemic+2 more
Dr. Ferrer BioPharma 101
Not applicableStudy completedNCT04799691
What this trial is testing

Comparison of 2 Ventilatory Support Strategies During Coronavirus Disease 2019 (Covid-19) Pneumonia

Who this might be right for
COVID-19
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 133
Not applicableUnknownNCT04270383
What this trial is testing

Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children

Who this might be right for
2019-nCoV
Beijing Children's Hospital 500
Not applicableUnknownNCT04273646
What this trial is testing

Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19

Who this might be right for
2019 Novel Coronavirus PneumoniaCOVID-19
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 48
Next Page